WO2006022409A1 - Hazardous substance scavenger and application apparatus and application method therefor - Google Patents

Hazardous substance scavenger and application apparatus and application method therefor Download PDF

Info

Publication number
WO2006022409A1
WO2006022409A1 PCT/JP2005/015633 JP2005015633W WO2006022409A1 WO 2006022409 A1 WO2006022409 A1 WO 2006022409A1 JP 2005015633 W JP2005015633 W JP 2005015633W WO 2006022409 A1 WO2006022409 A1 WO 2006022409A1
Authority
WO
WIPO (PCT)
Prior art keywords
harmful substance
scavenger
substance
harmful
egg antibody
Prior art date
Application number
PCT/JP2005/015633
Other languages
French (fr)
Japanese (ja)
Other versions
WO2006022409A8 (en
Inventor
Jun-Ichiro Arai
Mitsugu Yamashita
Original Assignee
Daikin Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daikin Industries, Ltd. filed Critical Daikin Industries, Ltd.
Publication of WO2006022409A1 publication Critical patent/WO2006022409A1/en
Publication of WO2006022409A8 publication Critical patent/WO2006022409A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23Immunoglobulins specific features characterized by taxonomic origin from birds

Definitions

  • the present invention relates to a biological surface that captures a harmful substance (20) by contact with a harmful substance (20) by being attached to a mucosal surface such as the nose or vulva, airway epithelial surface, or corneal surface.
  • the present invention relates to an adhering harmful substance trapping agent (10), and a spraying device (30) and spraying method thereof.
  • Japanese National Publication No. Hei 8-508240 discloses a method for preventing infection derived from wounds, burns or biomaterial forces in humans and animal hosts, and is based on a host defense mechanism prior to microbial attachment and biofilm formation. Disclosed is a method comprising the step of directly applying to the wound, burn or biomaterial an immunoglobulin composition in an amount sufficient to cultivate the microorganism for pre-phagocytosis in preparation for phagocytosis or sterilization. It is described that the composition of the present invention is particularly applicable to prevention of infection.
  • the present invention has been made in view of the strong point, and the object of the present invention is to capture harmful substances (20) such as viruses and the like, and to capture harmful substances that can be used easily at low cost. (1 0) and a spraying device (30) and a spraying method thereof.
  • the present invention to achieve the above object is a biological surface-attached harmful substance scavenger (10) that captures the harmful substance (20) by contact with the harmful substance (20),
  • chicken egg antibody (11) as a harmful substance-capturing component.
  • a harmful substance scavenger (10) it may be harmful by applying it to the site where the harmful substance (20) adheres or by spraying it on the surface in advance. Since the substance (20) is captured by the chicken egg antibody (11), a high preventive effect against infection by the harmful substance (20) can be obtained.
  • the harmful substance (20) can be removed by the egg antibody (11) by attaching the harmful substance capturing agent (10) to the surface of the harmful substance (20). Since it is trapped, it is possible to obtain an effect of preventing the infection after the harmful substances (20) are attached.
  • chicken egg antibody (11) is used as a harmful substance-capturing component, so that it is inexpensive and can be easily used such as coating and gauze because it is a substance attached to the surface of the living body rather than being injected.
  • the harmful substance-trapping agent (10) of the present invention may be in the form of a liquid in which the chicken egg antibody (11) is dissolved in a solvent, or in the form of a powder.
  • the particle size is 2 to 10 ⁇ m U. Inhaled viruses and other harmful substances (20) often adhere to the upper respiratory tract (40), but if the harmful substance scavenger (10) has a particle size of ⁇ ⁇ 10 m, it is the upper respiratory tract (40). Therefore, the trapping of harmful substances (20) is effectively carried out.
  • the harmful substance (20) to be captured by the harmful substance-trapping agent (10) of the present invention is, for example, bacteria, molds, winoles, and arenoregens.
  • the harmful substance-capturing agent (10) of the present invention is a liquid substance in which a chicken egg antibody (11) is dissolved in a solvent as a harmful substance-capturing component, the particle size of 2 to It contains hen egg antibody (11) as a harmful substance trapping component that can be sprayed in the form of a mist and sprayed in the case of a powder with a particle size of 2 ⁇ : LO / zm (30) It can be sprayed in the form of a mist.
  • FIG. 1 is a schematic diagram of a chicken egg antibody (11).
  • FIG. 2 is an explanatory diagram showing a method for removing harmful substances (20).
  • the harmful substance-capturing agent (10) is a liquid substance in which the chicken egg antibody (11) as a harmful substance-capturing component is dissolved in a solvent such as water.
  • This harmful substance-trapping agent (10) has a concentration of chicken egg antibody (11) of 0.01 to 23% by mass (preferably 0.5 to 8% by mass). Contains chicken egg antibody (11).
  • FIG. 1 shows a chicken egg antibody (11).
  • the chicken egg antibody (11) is a protein that specifically reacts (antigen-antibody reaction) with a specific harmful substance (20) (antigen), has a molecular size of 7-8 nm, and has a Y-shape. It has a molecular shape.
  • the pair of branches in the Y-shaped molecular form of chicken egg antibody (11) is called Fab (lla) and the trunk is called Fc (llb). Of these, the Fab (l la) part is a toxic substance (20) To capture.
  • the type of chicken egg antibody (11) corresponds to the type of harmful substance (20) that can be captured.
  • the harmful substance (20) captured by the chicken egg antibody (11) include bacteria, molds, viruses, allergens and mycoplasma.
  • Specific examples of bacteria include Gram-positive bacteria, Staphylococcus (S. aureus and Staphylococcus epidermidis), Micrococcus, Bacillus anthracis, Bacillus cereus, Bacillus subtilis, Acne, and Gram-negative. Examples include Pseudomonas aeruginosa, Serratia, Sephacia, Streptococcus pneumoniae, Legionella, and Mycobacterium tuberculosis.
  • molds examples include yeast, Aspergillus, Vesirius, and Cladosporum.
  • Viruses include varicella virus and measles virus that infect air when splashes are less than 5 ⁇ m, influenza virus, coronavirus (SAR S virus), adenovirus, mumps virus, and rubella virus that are splashes larger than 5 ⁇ m. And herpes viruses that are contact-infected.
  • allergens include pollen, mite allergen (mite digest), mold spores, and cat allergen (pet dander). Bacteria and fungi are not inactivated by chicken egg antibody (11), but they are bacteriostatic due to high adsorption effect, whereas viruses and allergens are sterilized.
  • the chicken egg antibody (11) can be produced by administering an antigen to a chick bird to produce an immunized egg, purifying the egg yolk powder power obtained by sterilizing and spray-drying the egg yolk liquid. . That is chicken Egg antibody (11) is easy and can be produced in large quantities.
  • glycerin In addition to toxic substance scavenger (10), glycerin, ethanol, polysorbate 80, sodium hydrogen phosphate, sodium dihydrogen phosphate, sodium hydroxide, hydrochloric acid, 1-menthol, no Occasional oil may be included.
  • This harmful substance-capturing agent (10) can be produced by dissolving the chicken egg antibody (11) in a solution of water or other additives dissolved in the solvent.
  • the tank of the portable spraying device (dispersing device) (30) is filled and used.
  • the spraying device (30) is for spraying a liquid harmful substance trapping agent (10) in the form of a mist in the form of droplets having a particle size of 2 to 10 m, and its type is particularly limited.
  • the type of spraying with pressurized air, the type of spraying with ultrasonic waves, the type of spraying with vibration, the type of spraying with rotation of a rotating disk, the type of spraying with static electricity It may be of any type.
  • the spraying device (30) sprays the harmful substance-trapping agent (10) in the form of droplets having a particle size of 2 to 10 m in the form of a mist onto the oral cavity, nasal cavity, eyes, or vulva.
  • the harmful substance scavenger (10) has adhered to the oral cavity, nasal cavity, eyes, or mucous membrane of the vulva, and has been invaded from harmful substances such as viruses (20) attached to the mucosa. Capture toxic substances (20).
  • harmful substances such as viruses that have entered the body (20) often adhere to the upper respiratory tract (40), but the harmful substance-trapping agent (10) injected into the oral cavity or nasal cavity has a particle size of 2-10. Because it is m, it reaches the upper airway (40) and stays there, where it traps harmful substances (20).
  • the harmful substance scavenger (10) described above is harmful when going to a place where there is a risk of being infected with harmful substances (20), for example, before getting on a train or before entering a crowd.
  • the harmful substance (20) is captured by the egg antibody (11), so that a high preventive effect against infection by the harmful substance (20) is obtained. be able to
  • the liquid harmful substance trapping agent (10) is used by being sprayed by the spray device (30), but is not particularly limited thereto, and is used as a gargle. You can also.
  • the harmful substance-capturing agent (10) is in the form of a powder having a particle diameter of 2 to 10 m and containing a chicken egg antibody (11) as a harmful substance-capturing component.
  • This harmful substance-capturing agent (10) is obtained by embedding a chicken egg antibody (11) in an excipient, a pH regulator and a tonicity agent, and the concentration of the chicken egg antibody (11) is 0.01 to 23. For example, it is one containing about 10 mg of chicken egg antibody (11) in 1 g of freeze-dried lg.
  • composition of the chicken egg antibody (11) is the same as in the first embodiment.
  • excipients include lactose, sucrose, D-manntol, D-sorbitol, denpun, pregelatinized starch, dextrin, crystalline cellulose, low-substituted hydroxypropyl cellulose, carboxymethylcellulose sodium Arabic gum, pullulan, light anhydrous caustic acid, synthetic aluminum silicate, magnesium aluminate metasilicate and the like.
  • Examples of the pH adjuster include sodium hydrogen phosphate, sodium dihydrogen phosphate, sodium hydroxide, hydrochloric acid and the like.
  • Examples of the tonicity agent include sodium chloride salt, glycerin, D-mannitol, D-sorbitol, glucose and the like.
  • the harmful substance-capturing agent (10) is prepared by weighing the egg antibody (11), excipient, pH adjusting agent, and tonicity agent, kneading them, and granulating them. It can be manufactured by sizing and mixing, and is used by being filled in a tank of a portable spraying device (30).
  • the spraying device (30) is for spraying powder that sprays a toxic substance trapping agent (10) in the form of powder with a particle size of 2 to 10 m, and its type is particularly limited is not.
  • a powdery harmful substance scavenger (10 to 10 m in diameter) is applied to the oral cavity, nasal cavity, eyes, or vulva by means of a spraying device (30).
  • a spraying device (30).
  • the harmful substance trapping agent 10 adheres to the oral cavity, nasal cavity, eyes, or mucous membrane of the vulva, and the harmful substances such as viruses (20) adhering to the mucous membrane are present. Captures harmful substances (20).
  • harmful substances such as viruses that have entered the body (20) often adhere to the upper respiratory tract (40), but the harmful substance-trapping agent (10) injected into the oral cavity or nasal cavity has a particle size power of ⁇ ⁇ Since it is 10 m, it reaches the upper airway (40) and stays there, where it traps harmful substances (20).
  • the chicken egg antibody (11) becomes active only in the presence of water, but in this case, it is activated by the water in the body.
  • the present invention provides a biological surface-attached harmful substance capturing agent (10) for capturing the harmful substance (20) by contact with the harmful substance (20), and a spraying device (30) and a spraying method thereof. Useful for.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

A hazardous substance scavenger (10) adhering to the surface of a living body which captures a hazardous substance (20) upon contact with the hazardous substance (20). This hazardous substance scavenger (10) contains a chicken egg antibody as a hazardous substance scavenger component.

Description

明 細 書  Specification
有害物質捕捉剤、並びに、その散布装置及び散布方法  Hazardous substance scavenger, spraying device and spraying method thereof
技術分野  Technical field
[0001] 本発明は、鼻、外陰部等の粘膜表面や気道上皮表面や角膜表面などに付着させ ることで、有害物質 (20)との接触によりその有害物質 (20)を捕捉する生体表面付着型 の有害物質捕捉剤 (10)、並びに、その散布装置 (30)及び散布方法に関する。  [0001] The present invention relates to a biological surface that captures a harmful substance (20) by contact with a harmful substance (20) by being attached to a mucosal surface such as the nose or vulva, airway epithelial surface, or corneal surface. The present invention relates to an adhering harmful substance trapping agent (10), and a spraying device (30) and spraying method thereof.
背景技術  Background art
[0002] 人体に対するウィルスの感染を予防する方法には種々のものがある。  There are various methods for preventing the infection of the human body with viruses.
[0003] 特表平 8— 508240号公報には、人間および動物宿主において創傷、火傷または 生体材料力 派生する感染を予防する方法であって、微生物付着および生体膜形 成前に宿主防御機制による食菌作用または殺菌に備えて微生物を先行食菌作用に カゝけるに十分な量の免疫グロブリン組成物を前記創傷、火傷または生体材料に直接 に塗布する過程を含む方法が開示されている。そして、この発明の組成物はとくに感 染の予防に適用できる、と記載されている。  [0003] Japanese National Publication No. Hei 8-508240 discloses a method for preventing infection derived from wounds, burns or biomaterial forces in humans and animal hosts, and is based on a host defense mechanism prior to microbial attachment and biofilm formation. Disclosed is a method comprising the step of directly applying to the wound, burn or biomaterial an immunoglobulin composition in an amount sufficient to cultivate the microorganism for pre-phagocytosis in preparation for phagocytosis or sterilization. It is described that the composition of the present invention is particularly applicable to prevention of infection.
[0004] ところで、インフルエンザウイルスに感染するのを予防する方法として、マスクを着用 すること、手洗いやうがいをすることを主として挙げることができる。しかしながら、マス クの着用の場合、飛沫を一時的に止めたとしても、飛沫核となったウィルス粒子を通 過させてしまうのを阻止することはできない。また、手洗いやうがいをする場合、ウィル スが粘膜に付着した直後に行わなければ効果がなく、タイミングを逸すれば経口や 経粘膜的にウィルスに感染して発病してしまうことになる。  [0004] By the way, as a method for preventing infection with influenza virus, it is mainly possible to wear a mask, wash hands and gargle. However, in the case of wearing a mask, even if the spray is temporarily stopped, it is not possible to prevent the virus particles that have become the spray core from passing through. In addition, when washing hands or gargles, if the virus is not applied immediately after adhering to the mucous membrane, it will not be effective, and if the timing is missed, the virus will be infected by oral or transmucosal infection.
[0005] 本発明は、力かる点に鑑みてなされたものであり、その目的とするところは、ウィルス などの有害物質 (20)を捕捉でき、しかも、安価で手軽に使用できる有害物質捕捉剤 (1 0)、並びに、その散布装置 (30)及び散布方法を提供することにある。  [0005] The present invention has been made in view of the strong point, and the object of the present invention is to capture harmful substances (20) such as viruses and the like, and to capture harmful substances that can be used easily at low cost. (1 0) and a spraying device (30) and a spraying method thereof.
発明の開示  Disclosure of the invention
[0006] 上記の目的を達成する本発明は、有害物質 (20)との接触によりその有害物質 (20)を 捕捉する生体表面付着型の有害物質捕捉剤 (10)であって、  [0006] The present invention to achieve the above object is a biological surface-attached harmful substance scavenger (10) that captures the harmful substance (20) by contact with the harmful substance (20),
有害物質捕捉成分として鶏卵抗体 (11)を含有することを特徴とする。 [0007] このような有害物質捕捉剤 (10)であれば、有害物質 (20)が付着するような部位に塗 布したり、或いは、吹きつけたりして予め表面付着させておくことにより、有害物質 (20) を鶏卵抗体 (11)によって捕捉するので、有害物質 (20)による感染の高い予防効果を 得ることができる。また、仮に有害物質 (20)が付着しても、この有害物質捕捉剤 (10)を 有害物質 (20)の付着部位に表面付着させることにより、有害物質 (20)を鶏卵抗体 (11) によって捕捉するので、有害物質 (20)が付着した後の感染の高 ヽ予防効果を得るこ とができる。しかも、有害物質捕捉成分として鶏卵抗体 (11)が用いられているので安 価であり、注射するものではなく生体表面付着型のものであるので塗布やうが 、など 手軽に使用することができる。 It contains chicken egg antibody (11) as a harmful substance-capturing component. [0007] In the case of such a harmful substance scavenger (10), it may be harmful by applying it to the site where the harmful substance (20) adheres or by spraying it on the surface in advance. Since the substance (20) is captured by the chicken egg antibody (11), a high preventive effect against infection by the harmful substance (20) can be obtained. In addition, even if harmful substances (20) are attached, the harmful substance (20) can be removed by the egg antibody (11) by attaching the harmful substance capturing agent (10) to the surface of the harmful substance (20). Since it is trapped, it is possible to obtain an effect of preventing the infection after the harmful substances (20) are attached. In addition, chicken egg antibody (11) is used as a harmful substance-capturing component, so that it is inexpensive and can be easily used such as coating and gauze because it is a substance attached to the surface of the living body rather than being injected.
[0008] 本発明の有害物質捕捉剤 (10)は、上記鶏卵抗体 (11)を溶媒に溶解させた液体状の ものであっても、また、粉体状のものであってもよい。  [0008] The harmful substance-trapping agent (10) of the present invention may be in the form of a liquid in which the chicken egg antibody (11) is dissolved in a solvent, or in the form of a powder.
[0009] 粉体状の場合、その粒径が 2〜 10 μ mであることが望ま U、。吸入したウィルス等 の有害物質 (20)は上気道 (40)に付着することが多いが、有害物質捕捉剤 (10)の粒径 力^〜 10 mであると、それが上気道 (40)に滞留するので、有害物質 (20)の捕捉が効 果的に営まれることとなる。  [0009] In the case of powder, it is desirable that the particle size is 2 to 10 μm U. Inhaled viruses and other harmful substances (20) often adhere to the upper respiratory tract (40), but if the harmful substance scavenger (10) has a particle size of ^ ~ 10 m, it is the upper respiratory tract (40). Therefore, the trapping of harmful substances (20) is effectively carried out.
[0010] ここで、本発明の有害物質捕捉剤 (10)によって捕捉する有害物質 (20)は、例えば、 細菌、カビ、ウイノレス、ァレノレゲンである。  [0010] Here, the harmful substance (20) to be captured by the harmful substance-trapping agent (10) of the present invention is, for example, bacteria, molds, winoles, and arenoregens.
[0011] 本発明の有害物質捕捉剤 (10)は、有害物質捕捉成分として鶏卵抗体 (11)を溶媒に 溶解させた液体状のものの場合、散布装置 (30)により粒径 2〜: LO mの液滴にして 霧状に噴射するようにすればよぐ有害物質捕捉成分として鶏卵抗体 (11)を含有する 粒径 2〜: LO /z mの粉体状のものの場合、散布装置 (30)によりそれを霧状に噴射する ようにすればよい。  [0011] When the harmful substance-capturing agent (10) of the present invention is a liquid substance in which a chicken egg antibody (11) is dissolved in a solvent as a harmful substance-capturing component, the particle size of 2 to It contains hen egg antibody (11) as a harmful substance trapping component that can be sprayed in the form of a mist and sprayed in the case of a powder with a particle size of 2 ~: LO / zm (30) It can be sprayed in the form of a mist.
[0012] このように有害物質捕捉剤 (10)を散布すれば、上記したように、有害物質捕捉剤 (10 )が上気道 (40)に滞留するので、有害物質 (20)の捕捉が効果的に営まれることとなる。 図面の簡単な説明  [0012] If the harmful substance scavenger (10) is sprayed in this way, the harmful substance scavenger (10) stays in the upper respiratory tract (40) as described above, so that the trapping of the harmful substance (20) is effective. Will be run. Brief Description of Drawings
[0013] [図 1]鶏卵抗体 (11)の模式的な図である。 [0013] Fig. 1 is a schematic diagram of a chicken egg antibody (11).
[図 2]有害物質 (20)の除去方法を示す説明図である。  FIG. 2 is an explanatory diagram showing a method for removing harmful substances (20).
発明を実施するための最良の形態 [0014] 以下、本発明の実施形態を詳細に説明する。 BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, embodiments of the present invention will be described in detail.
[0015] (実施形態 1)  [Embodiment 1]
第 1実施形態に係る有害物質捕捉剤 (10)は、有害物質捕捉成分としての鶏卵抗体 ( 11)を水などの溶媒に溶解させた液体状のものである。この有害物質捕捉剤 (10)は、 鶏卵抗体 (11)の濃度が 0. 01〜23質量% (好ましくは、 0. 5〜8質量%)であり、例え ば溶液 lml中に約 lOmg程度の鶏卵抗体 (11)を含有したものである。  The harmful substance-capturing agent (10) according to the first embodiment is a liquid substance in which the chicken egg antibody (11) as a harmful substance-capturing component is dissolved in a solvent such as water. This harmful substance-trapping agent (10) has a concentration of chicken egg antibody (11) of 0.01 to 23% by mass (preferably 0.5 to 8% by mass). Contains chicken egg antibody (11).
[0016] 図 1は、鶏卵抗体 (11)を示す。  FIG. 1 shows a chicken egg antibody (11).
[0017] 鶏卵抗体 (11)は、特定の有害物質 (20) (抗原)に対して特異的に反応 (抗原抗体反 応)するタンパク質であり、分子サイズが 7〜8nmであって、 Y字状の分子形態を有す る。鶏卵抗体 (11)の Y字状の分子形態の一対の枝部分を Fab(lla)、幹部分を Fc(llb )といい、これらのうち、 Fab(l la)の部分で有害物質 (20)を捕捉する。  [0017] The chicken egg antibody (11) is a protein that specifically reacts (antigen-antibody reaction) with a specific harmful substance (20) (antigen), has a molecular size of 7-8 nm, and has a Y-shape. It has a molecular shape. The pair of branches in the Y-shaped molecular form of chicken egg antibody (11) is called Fab (lla) and the trunk is called Fc (llb). Of these, the Fab (l la) part is a toxic substance (20) To capture.
[0018] 鶏卵抗体 (11)の種類は、捕捉しうる有害物質 (20)の種類に対応する。鶏卵抗体 (11) により捕捉される有害物質 (20)としては、例えば、細菌、カビ、ウィルス、アレルゲン及 びマイコプラズマを挙げることができる。具体的には、細菌としては、例えば、グラム陽 性菌であるブドウ球菌属 (黄色ブドウ球菌や表皮ブドウ球菌)、ミクロコッカス属、炭疽 菌、セレウス菌、枯草菌、ァクネ菌などや、グラム陰性菌である緑膿菌、セラチア菌、 セパシァ菌、肺炎球菌、レジオネラ菌、結核菌を挙げることができる。カビとしては、 例えば、酵母、ァスペルギルス、ベ-シリウス、クラドスポリゥムを挙げることができる。 ウィルスとしては、飛沫が 5 μ m以下で空気感染する水痘ウィルスや麻疹ウィルス、 飛沫が 5 μ mより大きくて飛沫感染するインフルエンザウイルス、コロナウィルス(SAR Sウィルス)、アデノウイルス、ムンプスウィルス、風疹ウィルス、接触感染するヘルべ スウィルスを挙げることができる。アレルゲンとしては、花粉、ダニアレルゲン (ダニ分 解物)、カビ胞子、ネコアレルゲン(ペットのふけ)を挙げることができる。これらのうち 細菌及びカビについては、鶏卵抗体 (11)により不活ィ匕されないものの、高い吸着効 果により静菌するのに対し、ウィルス及びアレルゲンについては、殺菌'不活化される  [0018] The type of chicken egg antibody (11) corresponds to the type of harmful substance (20) that can be captured. Examples of the harmful substance (20) captured by the chicken egg antibody (11) include bacteria, molds, viruses, allergens and mycoplasma. Specific examples of bacteria include Gram-positive bacteria, Staphylococcus (S. aureus and Staphylococcus epidermidis), Micrococcus, Bacillus anthracis, Bacillus cereus, Bacillus subtilis, Acne, and Gram-negative. Examples include Pseudomonas aeruginosa, Serratia, Sephacia, Streptococcus pneumoniae, Legionella, and Mycobacterium tuberculosis. Examples of molds include yeast, Aspergillus, Vesirius, and Cladosporum. Viruses include varicella virus and measles virus that infect air when splashes are less than 5 μm, influenza virus, coronavirus (SAR S virus), adenovirus, mumps virus, and rubella virus that are splashes larger than 5 μm. And herpes viruses that are contact-infected. Examples of allergens include pollen, mite allergen (mite digest), mold spores, and cat allergen (pet dander). Bacteria and fungi are not inactivated by chicken egg antibody (11), but they are bacteriostatic due to high adsorption effect, whereas viruses and allergens are sterilized.
[0019] 鶏卵抗体 (11)は、 -ヮトリに抗原を投与して免疫卵を生ませ、その卵黄液を殺菌及 び噴霧乾燥して得た卵黄粉体力も精製することで製造することができる。つまり、鶏 卵抗体 (11)は、容易で且つ大量の製造が可能である。 [0019] The chicken egg antibody (11) can be produced by administering an antigen to a chick bird to produce an immunized egg, purifying the egg yolk powder power obtained by sterilizing and spray-drying the egg yolk liquid. . That is chicken Egg antibody (11) is easy and can be produced in large quantities.
[0020] 有害物質捕捉剤 (10)には、その他に添加物として、グリセリン、エタノール、ポリソル ペート 80、リン酸水素ナトリウム、リン酸二水素ナトリウム、水酸化ナトリウム、塩酸、 1 —メントール、ノ、ッカ油などが含有されて 、てもよ ヽ。  [0020] In addition to toxic substance scavenger (10), glycerin, ethanol, polysorbate 80, sodium hydrogen phosphate, sodium dihydrogen phosphate, sodium hydroxide, hydrochloric acid, 1-menthol, no Occasional oil may be included.
[0021] この有害物質捕捉剤 (10)は、溶媒である水、或いは、それにその他の添加物を溶 解させた溶液に鶏卵抗体 (11)を溶解させることにより製造することができ、図 2に示す ように、携帯型の噴霧装置 (散布装置) (30)のタンクに充填されて用いられる。噴霧装 置 (30)は、液体状の有害物質捕捉剤 (10)を粒径 2〜10 mの液滴にして霧状に噴射 する液体噴霧用のものであって、その形式は特に限定されるものではなぐ例えば、 加圧空気により噴霧させるタイプ、超音波により噴霧させるタイプ、振動により噴霧さ せるタイプ、回転円盤の回転により噴霧させるタイプ、静電気により噴霧させるタイプ を挙げることができる力 どのようなタイプのものであってもよい。  [0021] This harmful substance-capturing agent (10) can be produced by dissolving the chicken egg antibody (11) in a solution of water or other additives dissolved in the solvent. As shown in the figure, the tank of the portable spraying device (dispersing device) (30) is filled and used. The spraying device (30) is for spraying a liquid harmful substance trapping agent (10) in the form of a mist in the form of droplets having a particle size of 2 to 10 m, and its type is particularly limited. For example, the type of spraying with pressurized air, the type of spraying with ultrasonic waves, the type of spraying with vibration, the type of spraying with rotation of a rotating disk, the type of spraying with static electricity It may be of any type.
[0022] 使用に際しては、噴霧装置 (30)により、口腔、鼻腔、目、或いは、外陰部に、有害物 質捕捉剤 (10)を粒径 2〜10 mの液滴にして霧状に噴射する。これにより、有害物質 捕捉剤 (10)が口腔、鼻腔、目、或いは、外陰部の粘膜に表面付着し、そこに付着して いたウィルス等の有害物質 (20)、或いは、外部から侵入してきた有害物質 (20)を捕捉 する。また、体内に侵入したウィルス等の有害物質 (20)は上気道 (40)に付着すること が多いが、口腔や鼻腔に噴射された有害物質捕捉剤 (10)は、粒径が 2〜10 mであ るので、上気道 (40)に達してそこに滞留し、そこで有害物質 (20)を捕捉する。  [0022] In use, the spraying device (30) sprays the harmful substance-trapping agent (10) in the form of droplets having a particle size of 2 to 10 m in the form of a mist onto the oral cavity, nasal cavity, eyes, or vulva. To do. As a result, the harmful substance scavenger (10) has adhered to the oral cavity, nasal cavity, eyes, or mucous membrane of the vulva, and has been invaded from harmful substances such as viruses (20) attached to the mucosa. Capture toxic substances (20). In addition, harmful substances such as viruses that have entered the body (20) often adhere to the upper respiratory tract (40), but the harmful substance-trapping agent (10) injected into the oral cavity or nasal cavity has a particle size of 2-10. Because it is m, it reaches the upper airway (40) and stays there, where it traps harmful substances (20).
[0023] 以上のような有害物質捕捉剤 (10)であれば、例えば、電車に乗る前や人混みに入 る前などの有害物質 (20)に感染するリスクのある場所に行くときに、有害物質 (20)が付 着するような部位に予め表面付着させておくことにより、有害物質 (20)を鶏卵抗体 (11) によって捕捉するので、有害物質 (20)による感染の高い予防効果を得ることができる  [0023] The harmful substance scavenger (10) described above is harmful when going to a place where there is a risk of being infected with harmful substances (20), for example, before getting on a train or before entering a crowd. By pre-attaching the surface to the site to which the substance (20) is attached, the harmful substance (20) is captured by the egg antibody (11), so that a high preventive effect against infection by the harmful substance (20) is obtained. be able to
[0024] また、例えば、風邪をひいている人の咳を吸い込んでしまった直後のように、仮に 有害物質 (20)が付着しても、この有害物質捕捉剤 (10)を有害物質 (20)の付着部位に 表面付着させることにより、有害物質 (20)を鶏卵抗体 (11)によって捕捉するので、有害 物質 (20)が付着した後の感染の高い予防効果を得ることができる。 [0025] さらに、有害物質捕捉成分として鶏卵抗体 (11)が用いられているので安価であり、 注射するものではなく生体表面付着型のものであり、 口腔、鼻腔、 目、或いは、外陰 部に噴霧装置 (30)で噴射するだけというように手軽に使用することができる。 [0024] Further, for example, even if a harmful substance (20) adheres, such as immediately after inhaling a cough of a person with a cold, this harmful substance scavenger (10) is used as a harmful substance (20 ), The harmful substance (20) is captured by the chicken egg antibody (11), so that a high preventive effect on infection after the harmful substance (20) is attached can be obtained. [0025] Furthermore, chicken egg antibody (11) is used as a harmful substance-capturing component, so that it is inexpensive and is not injected, but is attached to the surface of the living body, and is applied to the oral cavity, nasal cavity, eyes, or vulva. It can be used easily, just by spraying with the spray device (30).
[0026] なお、本実施形態では、液体状である有害物質捕捉剤 (10)を噴霧装置 (30)で噴射 して使用するようにしたが、特にこれに限定されず、うがい剤として使用することもでき る。  [0026] In the present embodiment, the liquid harmful substance trapping agent (10) is used by being sprayed by the spray device (30), but is not particularly limited thereto, and is used as a gargle. You can also.
[0027] (実施形態 2)  [Embodiment 2]
第 2実施形態に係る有害物質捕捉剤 (10)は、有害物質捕捉成分としての鶏卵抗体 ( 11)を含有した粒径が 2〜 10 mの粉体状のものである。この有害物質捕捉剤 (10)は 、鶏卵抗体 (11)が賦形剤、 pH調節剤及び張化剤に煉り込まれたものであって、鶏卵 抗体 (11)の濃度が 0. 01〜23質量% (好ましくは、 0. 5〜8質量%)であり、例えば凍 結乾燥状態のもの lg中に約 lOmg程度の鶏卵抗体 (11)を含有したものである。  The harmful substance-capturing agent (10) according to the second embodiment is in the form of a powder having a particle diameter of 2 to 10 m and containing a chicken egg antibody (11) as a harmful substance-capturing component. This harmful substance-capturing agent (10) is obtained by embedding a chicken egg antibody (11) in an excipient, a pH regulator and a tonicity agent, and the concentration of the chicken egg antibody (11) is 0.01 to 23. For example, it is one containing about 10 mg of chicken egg antibody (11) in 1 g of freeze-dried lg.
[0028] 鶏卵抗体 (11)の構成は、実施形態 1と同一である。  [0028] The composition of the chicken egg antibody (11) is the same as in the first embodiment.
[0029] 賦形剤としては、例えば、乳糖、白糖、 D—マン-トール、 D—ソルビトール、デンプ ン、 α化デンプン、デキストリン、結晶セルロース、低置換度ヒドロキシプロピルセル口 ース、カルボキシメチルセルロースナトリウム、アラビアゴム、プルラン、軽質無水ケィ 酸、合成ケィ酸アルミニウム、メタケイ酸アルミン酸マグネシウムなどが挙げられる。  [0029] Examples of excipients include lactose, sucrose, D-manntol, D-sorbitol, denpun, pregelatinized starch, dextrin, crystalline cellulose, low-substituted hydroxypropyl cellulose, carboxymethylcellulose sodium Arabic gum, pullulan, light anhydrous caustic acid, synthetic aluminum silicate, magnesium aluminate metasilicate and the like.
[0030] pH調節剤としては、例えば、リン酸水素ナトリウム、リン酸二水素ナトリウム、水酸ィ匕 ナトリウム、塩酸などが挙げられる。  [0030] Examples of the pH adjuster include sodium hydrogen phosphate, sodium dihydrogen phosphate, sodium hydroxide, hydrochloric acid and the like.
[0031] 張化剤としては、例えば、塩ィ匕ナトリウム、グリセリン、 D—マン-トール、 D—ソルビ トール、ブドウ糖などが挙げられる。  [0031] Examples of the tonicity agent include sodium chloride salt, glycerin, D-mannitol, D-sorbitol, glucose and the like.
[0032] この有害物質捕捉剤 (10)は、鶏卵抗体 (11)、賦形剤、 pH調整剤、及び、張化剤を それぞれ秤量した後に、それらを練合し、そして、それを造粒、整粒及び混合するこ とにより製造することができ、携帯型の散布装置 (30)のタンクに充填されて用いられる 。散布装置 (30)は、粒径 2〜10 mの粉体状の有害物質捕捉剤 (10)を霧状に噴射す る粉体噴霧用のものであって、その形式は特に限定されるものではない。  [0032] The harmful substance-capturing agent (10) is prepared by weighing the egg antibody (11), excipient, pH adjusting agent, and tonicity agent, kneading them, and granulating them. It can be manufactured by sizing and mixing, and is used by being filled in a tank of a portable spraying device (30). The spraying device (30) is for spraying powder that sprays a toxic substance trapping agent (10) in the form of powder with a particle size of 2 to 10 m, and its type is particularly limited is not.
[0033] 使用に際しては、図 2に示すように、散布装置 (30)により、口腔、鼻腔、 目、或いは、 外陰部に、粒径 2〜10 mの粉体状の有害物質捕捉剤 (10)を霧状に噴射する。これ により、有害物質捕捉剤 (10)が口腔、鼻腔、目、或いは、外陰部の粘膜に表面付着し 、そこに付着していたウィルス等の有害物質 (20)、或いは、外部から侵入してきた有 害物質 (20)を捕捉する。また、体内に侵入したウィルス等の有害物質 (20)は上気道 (4 0)に付着することが多いが、口腔や鼻腔に噴射された有害物質捕捉剤 (10)は、粒径 力^〜 10 mであるので、上気道 (40)に達してそこに滞留し、そこで有害物質 (20)を 捕捉する。なお、鶏卵抗体 (11)は、水分の存在下でのみ活性となるが、この場合、体 内の水分によって活性ィ匕される。 [0033] In use, as shown in FIG. 2, a powdery harmful substance scavenger (10 to 10 m in diameter) is applied to the oral cavity, nasal cavity, eyes, or vulva by means of a spraying device (30). ) In the form of a mist. this As a result, the harmful substance trapping agent (10) adheres to the oral cavity, nasal cavity, eyes, or mucous membrane of the vulva, and the harmful substances such as viruses (20) adhering to the mucous membrane are present. Captures harmful substances (20). In addition, harmful substances such as viruses that have entered the body (20) often adhere to the upper respiratory tract (40), but the harmful substance-trapping agent (10) injected into the oral cavity or nasal cavity has a particle size power of ~ ~ Since it is 10 m, it reaches the upper airway (40) and stays there, where it traps harmful substances (20). The chicken egg antibody (11) becomes active only in the presence of water, but in this case, it is activated by the water in the body.
[0034] 作用効果は、実施形態 1と同一である。 [0034] The operational effects are the same as in the first embodiment.
産業上の利用可能性  Industrial applicability
[0035] 本発明は、有害物質 (20)との接触によりその有害物質 (20)を捕捉する生体表面付 着型の有害物質捕捉剤 (10)、並びに、その散布装置 (30)及び散布方法に関して有用 である。 [0035] The present invention provides a biological surface-attached harmful substance capturing agent (10) for capturing the harmful substance (20) by contact with the harmful substance (20), and a spraying device (30) and a spraying method thereof. Useful for.

Claims

請求の範囲 The scope of the claims
[1] 有害物質 (20)との接触によりその有害物質 (20)を捕捉する生体表面付着型の有害 物質捕捉剤 (10)であって、  [1] A biological surface-attached harmful substance scavenger (10) that captures the harmful substance (20) by contact with the harmful substance (20),
有害物質捕捉成分として鶏卵抗体 (11)を含有する有害物質捕捉剤。  A harmful substance-capturing agent containing a chicken egg antibody (11) as a harmful substance-capturing component.
[2] 請求項 1に記載された有害物質捕捉剤 (10)にお 、て、 [2] In the hazardous substance scavenger (10) according to claim 1,
上記鶏卵抗体 (11)を溶媒に溶解させた液体状である有害物質捕捉剤。  A harmful substance-capturing agent in a liquid form in which the chicken egg antibody (11) is dissolved in a solvent.
[3] 請求項 1に記載された有害物質捕捉剤 (10)にお 、て、 [3] In the hazardous substance scavenger (10) according to claim 1,
粉体状である有害物質捕捉剤。  A harmful substance scavenger in powder form.
[4] 請求項 3に記載された有害物質捕捉剤 (10)において、 [4] In the hazardous substance scavenger (10) according to claim 3,
粒径が 2〜10 μ mである有害物質捕捉剤。  Hazardous substance scavenger with a particle size of 2-10 μm.
[5] 請求項 1乃至 4のいずれかに記載された有害物質捕捉剤 (10)において、 [5] In the hazardous substance scavenger (10) according to any one of claims 1 to 4,
上記有害物質 (20)が細菌、カビ、ウィルス及びアレルゲンのうち力 選ばれる少なく とも 1つである有害物質捕捉剤。  A hazardous substance scavenger wherein the harmful substance (20) is at least one selected from bacteria, molds, viruses and allergens.
[6] 有害物質捕捉成分として鶏卵抗体 (11)を溶媒に溶解させた液体状の有害物質捕 捉剤 (10)を、粒径 2〜10 mの液滴にして霧状に噴射する有害物質捕捉剤 (10)の散 布装置。 [6] Hazardous substance sprayed in the form of droplets with a particle size of 2 to 10 m in the form of a liquid harmful substance trapping agent (10) in which chicken egg antibody (11) is dissolved in a solvent as a harmful substance trapping component Scattering device (10).
[7] 有害物質捕捉成分として鶏卵抗体 (11)を含有する粒径 2〜10 mの粉体状の有害 物質捕捉剤 (10)を霧状に噴射する有害物質捕捉剤 (10)の散布装置。  [7] Spraying device for toxic substance scavenger (10) spraying powdery toxic substance scavenger (10) with particle size of 2 to 10 m containing chicken egg antibody (11) as a toxic substance scavenger .
[8] 有害物質捕捉成分として鶏卵抗体 (11)を溶媒に溶解させた液体状の有害物質捕 捉剤 (10)を、粒径 2〜10 mの液滴にして霧状に噴射する有害物質捕捉剤 (10)の散 布方法。  [8] Toxic substance sprayed in the form of a mist of 2 to 10 m droplets of liquid harmful substance trapping agent (10) in which egg antibody (11) is dissolved in a solvent as a harmful substance-capturing component How to spread the scavenger (10).
[9] 有害物質捕捉成分として鶏卵抗体 (11)を含有する粒径 2〜10 mの粉体状の有害 物質捕捉剤 (10)を霧状に噴射する有害物質捕捉剤 (10)の散布方法。  [9] Spraying method of harmful substance scavenger (10) spraying powdery harmful substance scavenger (10) containing hen egg antibody (11) as a harmful substance scavenger component and having a particle size of 2 to 10 m .
PCT/JP2005/015633 2004-08-27 2005-08-29 Hazardous substance scavenger and application apparatus and application method therefor WO2006022409A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004247800A JP2006063019A (en) 2004-08-27 2004-08-27 Harmful substance-catching agent, and spray device and spray method therefor
JP2004-247800 2004-08-27

Publications (2)

Publication Number Publication Date
WO2006022409A1 true WO2006022409A1 (en) 2006-03-02
WO2006022409A8 WO2006022409A8 (en) 2008-08-07

Family

ID=35967606

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/015633 WO2006022409A1 (en) 2004-08-27 2005-08-29 Hazardous substance scavenger and application apparatus and application method therefor

Country Status (2)

Country Link
JP (1) JP2006063019A (en)
WO (1) WO2006022409A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5732192B2 (en) * 2009-10-14 2015-06-10 日本ゼトック株式会社 Oral composition

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608217A (en) * 1983-06-29 1985-01-17 ザ・スト−ル・リサ−チ・アンド・デイベロツプメント・コ−ポレ−シヨン Skin deodorant composition
JPS62175426A (en) * 1986-01-27 1987-08-01 Kazufumi Shimizu Antibody and spraying agent containing said substance as active component
JPH01313438A (en) * 1988-06-13 1989-12-18 Taiyo Kagaku Co Ltd Anti-periodontosis composition
JPH01313439A (en) * 1988-06-13 1989-12-18 Taiyo Kagaku Co Ltd Anti-acne vulgaris bacteria skin drug for external use
JPH02121910A (en) * 1988-10-28 1990-05-09 Kanebo Ltd Cosmetic for pimple
WO1993006862A1 (en) * 1991-10-11 1993-04-15 Toray Industries, Inc. Antibody composition
JPH05105635A (en) * 1991-10-16 1993-04-27 Banyu Pharmaceut Co Ltd Antiviral agent
JPH0710728A (en) * 1993-06-28 1995-01-13 Lion Corp Composition for oral cavity
JP2002212100A (en) * 2000-12-07 2002-07-31 Pharmafoods Kenkyusho:Kk Sphingo lipid composition for preventing and treating pimple

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608217A (en) * 1983-06-29 1985-01-17 ザ・スト−ル・リサ−チ・アンド・デイベロツプメント・コ−ポレ−シヨン Skin deodorant composition
JPS62175426A (en) * 1986-01-27 1987-08-01 Kazufumi Shimizu Antibody and spraying agent containing said substance as active component
JPH01313438A (en) * 1988-06-13 1989-12-18 Taiyo Kagaku Co Ltd Anti-periodontosis composition
JPH01313439A (en) * 1988-06-13 1989-12-18 Taiyo Kagaku Co Ltd Anti-acne vulgaris bacteria skin drug for external use
JPH02121910A (en) * 1988-10-28 1990-05-09 Kanebo Ltd Cosmetic for pimple
WO1993006862A1 (en) * 1991-10-11 1993-04-15 Toray Industries, Inc. Antibody composition
JPH05105635A (en) * 1991-10-16 1993-04-27 Banyu Pharmaceut Co Ltd Antiviral agent
JPH0710728A (en) * 1993-06-28 1995-01-13 Lion Corp Composition for oral cavity
JP2002212100A (en) * 2000-12-07 2002-07-31 Pharmafoods Kenkyusho:Kk Sphingo lipid composition for preventing and treating pimple

Also Published As

Publication number Publication date
WO2006022409A8 (en) 2008-08-07
JP2006063019A (en) 2006-03-09

Similar Documents

Publication Publication Date Title
US5897872A (en) Iodine-containing nasal moisturizing saline solution
US6171611B1 (en) Iodine-containing nasal moisturizing saline and mouthwash solutions
JP4744533B2 (en) Spray-dried polymer type collectin protein and method for producing the same
EA016072B1 (en) Use of calcium salt formulation for alteration of biophysical properties of mucosal lining
US9433637B2 (en) Method for inhibiting influenza virus infection
JPH08508240A (en) Methods and compositions for direct transfer of passive immunity
AU2017277897B2 (en) Microparticles comprising a sulphur-containing compound
JP2007510712A (en) Bactericidal composition and methods for making and using the same
JP2010270079A (en) Environmental substance-treating agent
WO2006022409A1 (en) Hazardous substance scavenger and application apparatus and application method therefor
WO2010134942A1 (en) Electrostatically charged multi-acting nasal application, product and method
JP2005206547A (en) Virus-capturing composition and virus-capturing filter in which the composition is adsorbed
WO2010005637A2 (en) Electrostatically charged multi-acting nasal application, product, and method
JP4972714B2 (en) Electrostatically charged multi-action nasal application, product and method
JP7084627B2 (en) Composition for preventing viral infections
JP4684377B2 (en) Pollen allergy prevention agent
JP2003116907A (en) External use lesion protective material
JP6039670B2 (en) Method for producing dry extract
CN101842318A (en) Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
WO2023044132A2 (en) Use of chitosan complexes or compositions to reduce infiltration of environmental factors into the brain
WO2000037069A1 (en) New utilization of alpha-hidroxy-propionic acid in medicine
Scherließ Nasal administration of vaccines
RU2780397C2 (en) Microparticles containing sulfur-containing compounds
Ghosh et al. Clays in the Global War Against COVID-19: Why are They Preferable Over the Conventional Weaponry?
CN113142704A (en) Epidemic prevention mask and using method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP